These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 831516)

  • 21. Biochemical methods for predicting metastatic ability of prostatic cancer utilizing the dunning R-3327 rat prostatic adenocarcinoma system as a model.
    Lowe FC; Isaacs JT
    Cancer Res; 1984 Feb; 44(2):744-52. PubMed ID: 6537899
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gross and microscopic pathology of induced prostatic complex tumors arising in Lobund-Wistar rats.
    Cohen MB; Heidger PM; Lubaroff DM
    Cancer Res; 1994 Feb; 54(3):626-8. PubMed ID: 7508335
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Histology, histochemistry, and acid phosphatase of Noble (Nb) rat prostate adenocarcinomas and treatment of an androgen-dependent Nb rat prostate adenocarcinoma.
    Drago JR; Goldman LB; Maurer RE; Eckels DD; Gershwin ME
    J Natl Cancer Inst; 1980 Apr; 64(4):931-7. PubMed ID: 6929004
    [No Abstract]   [Full Text] [Related]  

  • 24. Novel syngeneic pseudo-orthotopic prostate cancer model: vascular, mitotic and apoptotic responses to castration.
    Frost GI; Lustgarten J; Dudouet B; Nyberg L; Hartley-Asp B; Borgström P
    Microvasc Res; 2005 Jan; 69(1-2):1-9. PubMed ID: 15797254
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The LNCaP cell line--a new model for studies on human prostatic carcinoma.
    Horoszewicz JS; Leong SS; Chu TM; Wajsman ZL; Friedman M; Papsidero L; Kim U; Chai LS; Kakati S; Arya SK; Sandberg AA
    Prog Clin Biol Res; 1980; 37():115-32. PubMed ID: 7384082
    [No Abstract]   [Full Text] [Related]  

  • 26. The effect of castanospermine on the metastatic properties of prostate cancer cells.
    Yee CS; Schwab ED; Lehr JE; Quigley M; Pienta KJ
    Anticancer Res; 1997; 17(5A):3659-63. PubMed ID: 9413219
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A metastatic human prostate cancer model using intraprostatic implantation of tumor produced by PC-3 neolacZ transfected cells.
    Tsingotjidou AS; Ahluwalia R; Zhang X; Conrad H; Emmanouilides C
    Int J Oncol; 2003 Dec; 23(6):1569-74. PubMed ID: 14612928
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Susceptibility of Lobund-Wistar x Copenhagen hybrid rats to autochthonous prostate carcinogenesis.
    Suckow MA; Wolter W; Pollard M
    Prostate; 2005 Jul; 64(2):203-8. PubMed ID: 15712219
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of an animal model for prostate cancer cell metastasis to adult human bone.
    Tsingotjidou AS; Zotalis G; Jackson KR; Sawyers C; Puzas JE; Hicks DG; Reiter R; Lieberman JR
    Anticancer Res; 2001; 21(2A):971-8. PubMed ID: 11396190
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The evaluation of heparin in control of metastasis of Nb rat androgen-insensitive prostate carcinoma.
    Drago JR; Weed P; Fralisch A
    Anticancer Res; 1984; 4(3):171-2. PubMed ID: 6540544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Flow cytometric analysis of R3327 rat prostate adenocarcinoma grown in vivo and in vitro.
    Claflin AJ; Pollack A; Malinin T; Block NL; Irvin GL
    J Natl Cancer Inst; 1982 Jul; 69(1):79-87. PubMed ID: 6954325
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development and characteristics of the available animal model systems for the study of prostatic cancer.
    Isaacs JT
    Prog Clin Biol Res; 1987; 239():513-76. PubMed ID: 3309963
    [No Abstract]   [Full Text] [Related]  

  • 33. Animal models of prostate cancer.
    Russell PJ; Voeks DJ
    Methods Mol Med; 2003; 81():89-112. PubMed ID: 12725117
    [No Abstract]   [Full Text] [Related]  

  • 34. Nb rat prostate adenocarcinoma model: metastasis.
    Drago JR; Curley RM; Sipio JC
    Anticancer Res; 1985; 5(2):193-6. PubMed ID: 2581494
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metastasis-enhancing effect of heparin and its relationship to a lipoprotein factor.
    Chan SY; Pollard M
    J Natl Cancer Inst; 1980 May; 64(5):1121-5. PubMed ID: 6929014
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemotherapeutic and hormonal considerations of the Nb rat prostatic adenocarcinoma model.
    Drago JR; Goldman LB; Gershwin ME
    Prog Clin Biol Res; 1980; 37():325-63. PubMed ID: 7384092
    [No Abstract]   [Full Text] [Related]  

  • 37. Cell cycle-independent death of prostate adenocarcinoma is induced by the trk tyrosine kinase inhibitor CEP-751 (KT6587).
    Dionne CA; Camoratto AM; Jani JP; Emerson E; Neff N; Vaught JL; Murakata C; Djakiew D; Lamb J; Bova S; George D; Isaacs JT
    Clin Cancer Res; 1998 Aug; 4(8):1887-98. PubMed ID: 9717816
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Murine androgen-independent neuroendocrine carcinoma promotes metastasis of human prostate cancer cell line LNCaP.
    Uchida K; Masumori N; Takahashi A; Itoh N; Kato K; Matusik RJ; Tsukamoto T
    Prostate; 2006 Apr; 66(5):536-45. PubMed ID: 16372327
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of the Dunning R3327H prostatic adenocarcinoma: an appropriate animal model for prostatic cancer.
    Smolev JK; Heston WD; Scott WW; Coffey DS
    Cancer Treat Rep; 1977; 61(2):273-87. PubMed ID: 872132
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The nude mouse--its use as tumor-bearing model of the prostate.
    Gittes RF
    Prog Clin Biol Res; 1980; 37():31-7. PubMed ID: 7384090
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.